<SEC-DOCUMENT>0001628280-24-005282.txt : 20240402
<SEC-HEADER>0001628280-24-005282.hdr.sgml : 20240402
<ACCEPTANCE-DATETIME>20240216132107
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001628280-24-005282
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zai Lab Ltd
		CENTRAL INDEX KEY:			0001704292
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
		BUSINESS PHONE:		862161632588

	MAIL ADDRESS:	
		STREET 1:		4560 JINKE ROAD
		STREET 2:		BLDG. 1, 4F, PUDONG
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			201210
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i21b1d786580a4cf7b457147ba55c23d0_1"></div><div style="min-height:153.36pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-top:12pt;padding-right:0.95pt"><img alt="image_2.jpg" src="image_2.jpg" style="height:32px;margin-bottom:5pt;vertical-align:text-bottom;width:121px"></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">SIDLEY AUSTIN LLP</font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">1501 K STREET, N.W.</font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">WASHINGTON, D.C. 20005</font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">+1 202 736 8000</font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">+1 202 736 8711 FAX</font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">AMERICA  &#8226;  ASIA PACIFIC  &#8226;  EUROPE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font><br></font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">+1 202 736 8387</font></div><div style="padding-left:0.95pt;padding-right:0.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:154%">SBARROS&#64;SIDLEY.COM</font></div></td></tr></table></div><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div id="i21b1d786580a4cf7b457147ba55c23d0_61"></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">February 16, 2024</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">VIA EDGAR</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission<br>Division of Corporation Finance</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Office of Life Sciences<br>100 F Street, N.E.<br>Washington, D.C. 20549</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attn&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Jennifer Gowetski</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;            Andrew Mew</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Re&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Zai Lab, Ltd.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Amendment No. 1 to Form 10-K for Fiscal Year Ended December 31, 2022</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Response dated January 5, 2024</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;File No. 001-38205</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Ladies and Gentlemen&#58;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">On behalf of our client, Zai Lab, Limited, an exempted company incorporated in the Cayman Islands (the &#8220;Company&#8221;), we submit to the staff (the &#8220;Staff&#8221;) of the Securities and Exchange Commission (the &#8220;Commission&#8221;) this letter setting forth the Company&#8217;s responses to the comment contained in the Staff&#8217;s letter dated January 16, 2024 on the Company&#8217;s Amendment No. 1 to the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and the Company&#8217;s response dated January 5, 2024. To assist your review, the Staff&#8217;s comment is repeated in italics and is followed by the Company&#8217;s response. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. 1 to Form 10-K for Fiscal Year Ended December 31, 2022</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections, page 3</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:9pt">Your response to prior comment 2 indicates that you relied upon information provided in response to&#160;the D&#38;O Questionnaires and that you are not aware of any current members of your board who are officials of the Chinese Communist Party.&#160; Although your response indicates that you did not consider affiliations that predated your board members&#8217;&#160;tenure on your board, we note your disclosure that there are no officials of the Chinese Communist Party who are members of your board.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Please tell us in more detail how you considered the profile of Mr. Kai-Xian Chen. In particular, we note he is a Member of the Chief Specialists Board and Deputy Chief Technical Officer of the major science and technology projects &#8220;innovative drugs and modernization of traditional Chinese medicine&#8221; and &#8220;Innovative Drug Research &#38;&#160;Development,&#8221; where he participated in the organization and promotion of new drug research and development for China&#8217;s 10th - 13th Five Year Plans.&#160;We further note Mr. Chen was a Principal Scientist </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.5pt;font-weight:400;line-height:120%">Sidley Austin (DC) LLP is a Delaware limited liability partnership doing business as Sidley Austin LLP and practicing in affiliation with other Sidley Austin partnerships.</font></td></tr></table></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:153.36pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Securities and Exchange Commission&#160;&#160;&#160;&#160;- 1 -&#160;&#160;&#160;&#160;February 16, 2024</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">for two National Basic Research Programs by the Ministry of Science and Technology as well as a Member of the&#160;National Committee of the Chinese People&#8217;s Political Consultative Conference.&#160; Please describe his various roles and provide us with your analysis of whether any of those roles at any point in time made him a CCP official.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Please also tell us how you considered whether Mr. Chen&#160;has any current or prior memberships on, or affiliations with, committees of the Chinese Communist Party that are not addressed in his biography on page 11&#160;of your proxy statement.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%;padding-left:13.8pt">Please tell us whether Mr. Chen&#160;is a member of the Chinese Communist Party.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Response to Comment 1&#58;</font></div><div style="margin-bottom:12pt;padding-left:35.4pt;text-indent:0.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Consideration of Professor Chen&#8217;s profile and his various roles in our analysis as to whether these roles made him a CCP official</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company&#8217;s practice with respect to verifying the profile of all directors is to have such individuals submit completed D&#38;O Questionnaires to the Company along with a certification as to the truthfulness and accuracy of their responses to the D&#38;O Questionnaire.   The Company followed this practice to verify Professor Kai Xian Chen&#8217;s profile.  In his response to the D&#38;O Questionnaire, Professor Chen confirmed to the Company that he is not an official of the Chinese Communist Party (the &#8220;CCP&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Following receipt of the Staff&#8217;s January 16 letter, the Company and its external legal counsel met with Professor Chen to discuss his previous and current roles and affiliations.  Professor Chen&#8217;s certification in his response to our D&#38;O Questionnaire that he is not an official of the CCP was confirmed in our subsequent discussion with him following receipt of the Staff&#8217;s January 16 letter. The Company also conducted an independent search of available media relating to Professor Chen&#8217;s biography.  Based on these actions, the Company has confirmed that Professor Chen is not an official of the CCP nor has he been a CCP official during his tenure with the Company&#8217;s Board of Directors (the &#8220;Board&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company notes that the term &#8220;CCP official&#8221; is not defined under the laws, rules, or regulations of the People&#8217;s Republic of China (&#8220;China&#8221;).  The term &#8220;CCP official&#8221; is also not defined under the Holding Foreign Company&#8217;s Accountable Act (the &#8220;HFCAA&#8221;) and related SEC rules.  In determining that Professor Chen is not a CCP official, the Company considered references to the term in the HFCAA and related SEC rules, as well as definitions of the term used by third-party sources, institutions of the Chinese government, and guidance from our local counsel in China, the Zhonglun Law Firm.  While Professor Chen has held various prominent research and academic positions, those positions have been only as a scientific advisor. At no time has Professor Chen held any positions with the government of China with decision-making authority within the CCP.  In addition, Professor Chen confirmed to us that he has never been an official of the CCP.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:153.36pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Securities and Exchange Commission&#160;&#160;&#160;&#160;- 2 -&#160;&#160;&#160;&#160;February 16, 2024</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Below is certain additional information considered by the Company in relation to positions highlighted in the Staff&#8217;s January 16 letter and otherwise held by Professor Chen and referenced in his biography as provided on page 11 of the proxy statement&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">Professor Chen has held and continues to hold research positions within project-based advisory initiatives of various organizations relating to the Chinese bio-pharmaceutical industry&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.8pt">As noted in the Staff&#8217;s January 16 letter, Professor Chen assisted in administering the major science and technology projects &#8220;innovative drugs and modernization of traditional Chinese medicine&#8221; and &#8220;Innovative Drug Research &#38;&#160;Development&#8221; since 2001, including by participating in the organization and promotion of new drug research and development for China&#8217;s 10th - 13th Five Year Plans.  None of these are official positions within the CCP, government authorities, state-owned enterprises, or other public institutions within China. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.8pt">Prior to joining the Company&#8217;s Board of Directors, Professor Chen held roles as a Principal Scientist for two National Basic Research Programs administered by the Ministry of Science and Technology from 1998 to 2009. Professor Chen was the President of the Shanghai Association for Science and Technology, an academic organization whose primary purpose is to promote collaboration and exchange between scientists and which occasionally provides advice with respect to local level government initiatives in the science and technology industry, from 2011 to 2018. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:100%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.8pt">Prior to serving on the Company&#8217;s Board, Professor Chen was a member of the National Committee of the Chinese People&#8217;s Political Consultative Conference (the &#8220;Consultative Conference&#8221;) from 2007 to 2017. Professor Chen served as a member of the group focused on the science and technology industry, and was one of approximately 2,000 members, of the Consultative Conference, which was an advisory body formed for the purpose of proposing reforms. In this role, Professor Chen provided proposals relating to pharmaceutical drug research and development in China, such as proposals for reforms in the regulatory approval processes in the Chinese biopharmaceutical industry. Professor Chen ceased to be a member of the Consultative Conference in 2017. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.8pt">Similarly, before joining the Company&#8217;s Board, Professor Chen held positions within academia. Professor Chen was the President of Shanghai University of Traditional Chinese Medicine (&#8220;SUTCM&#8221;), a public university, from 2005 to 2014. Professor Chen was Deputy Director General and ultimately the Director General of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (&#8220;SIMM&#8221;), an academic and research organization focused on the research and development of new and generic pharmaceutical products. He held these roles between 1993 to 2004. Professor Chen is currently a professor at SIMM. SUTCM and SIMM are well-known educational and research institutions. Similar to many of the leading public universities and research-oriented institutions in the United States, neither SUTCM nor SIMM have policy-making authority, and neither are considered to be government agencies of China.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:153.36pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Securities and Exchange Commission&#160;&#160;&#160;&#160;- 3 -&#160;&#160;&#160;&#160;February 16, 2024</font></div><div><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Committee memberships or affiliations</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company has not identified any current or prior memberships or affiliations for Professor Chen beyond those disclosed in his biography on page 11 of our proxy statement that should be considered in connection with its analysis of whether Professor Chen is an official of the CCP. During the meeting between the Company, its external counsel, and Professor Chen, external counsel specifically asked Professor Chen whether he holds any current or prior memberships or affiliations that are not addressed in his biography on page 11 of our proxy statement that should be considered as part of its analysis of whether Professor Chen is an official of the CCP. Professor Chen confirmed that he does not hold and has not held any such committee memberships or affiliations. </font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Membership with the Chinese Communist Party</font></div><div style="margin-bottom:12pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Professor Chen is a member of the CCP. Third-party sources estimate that the CCP has approximately 97 million adult members, and another 184 million people under the age of 18 belong to the CCP&#8217;s Young Pioneers and Youth League. As these statistics reveal, membership with the CCP is not uncommon in China, and such membership does not cause Professor Chen to be an official of the CCP.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Our additional diligence further confirms the appropriateness of our reliance on Professor Chen&#8217;s certification in his D&#38;O questionnaire response that he is not an official of the CCP and supports our disclosure that there are no officials of the Chinese Communist Party who are members of our Board. We hope that the foregoing has been responsive to the Staff&#8217;s comments. If you have any questions about this letter or require any further information, please call Sara von Althann of Sidley Austin LLP at (202) 736-8715 or Sonia Barros of Sidley Austin LLP at (202) 736-8387.</font></div><div><font><br></font></div><div style="padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sincerely,<br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Sonia Barros<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Sonia Barros</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">cc&#58;  &#160;&#160;&#160;&#160;Yajing Chen</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">F. Ty Edmondson</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Bruce Blefeld</font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Aslynn Hogue</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_2.jpg
<TEXT>
begin 644 image_2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #K WD# 2(  A$! Q$!_\0
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M2S0_^@SI_P#X%1_XT?\ "6:'_P!!G3__  *C_P : -:BLG_A+-#_ .@SI_\
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M163_ ,)9H?\ T&=/_P# J/\ QH_X2S0_^@SI_P#X%1_XT :U%9/_  EFA_\
M09T__P "H_\ &C_A+-#_ .@SI_\ X%1_XT :U%9/_"6:'_T&=/\ _ J/_&C_
M (2S0_\ H,Z?_P"!4?\ C0!K45D_\)9H?_09T_\ \"H_\:/^$LT/_H,Z?_X%
M1_XT :U%9/\ PEFA_P#09T__ ,"H_P#&C_A+-#_Z#.G_ /@5'_C0!K45D_\
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M>'__  6P_P#Q-<3^R%^S3I/[*_P5TKP?9>7<ZN_^F:SJ*#_C[O& WL"1G8H
M1!Q\JC/))/M= !117S_^W-^T8/V9?V=M?\46DJIXBO,:7HBL ?\ 3)5;:^#P
M1&JO)@\'R\=Z /A3_@JY^W%-JVK7_P $? VH-%I]FWE^)]0MI"#<3#K9*1_
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M]%T>RAT[2M/@2VM;2W7;'#$BA511V  %:% !1110!_/7_P %(?\ D]KXI?\
M7[;_ /I)!7S77TI_P4A_Y/:^*7_7[;_^DD%?-= !1110!^E/_!$/_DJ?Q+_[
M UO_ .CS7Z_U^0'_  1#_P"2I_$O_L#6_P#Z/-?K_0 5\_\ [?G_ "9M\6/^
MP*__ *&M?0%?/_[?G_)FWQ8_[ K_ /H:T ?SKT444 %%%% !17U#X#_X)K?'
MOXE>"]%\5:!X7L;K1=8M([VSF?5[:-GB=0RDJS@C@]"*WO\ AT_^TE_T*&G_
M /@[M/\ XY0!\@45]?\ _#I_]I+_ *%#3_\ P=VG_P <H_X=/_M)?]"AI_\
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M_ VT_P#CU'_#MW]I+_HENH?^!MI_\>H _53_ ()/_P#)DOA#_K]U'_TKEK[
MKYI_X)V?"WQ3\&_V5?#7A;QEI$FAZ_:W5[)-932([(KW,CH<HS+RI!Z]Z^EJ
M "J.NZ'I_B;1;_1]6LX=0TO4+>2UNK2X7='-$ZE71AW!4D'ZU>HH _G6_;:_
M99U#]E'XU7_AW;-/X7O]U[H.H2#/G6I;_5LW0R1GY&]<*V '%> 5_1-^V_\
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M\GM?%+_K]M__ $D@KYKH **** /TI_X(A_\ )4_B7_V!K?\ ]'FOU_K\@/\
M@B'_ ,E3^)?_ &!K?_T>:_7^@ KY_P#V_/\ DS;XL?\ 8%?_ -#6OH"OG_\
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MXC.,CIZU^J7_  MCP1_T.7A__P &D'_Q= '5T5RG_"V/!'_0Y>'_ /P:0?\
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M110!_1[^Q3_R:/\ "'_L6;'_ -%+7M=>*?L4_P#)H_PA_P"Q9L?_ $4M>UT
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M);S!]?FC3VWGNIH ^T_V+?V7=._93^"NG>&D$5QXCO,7NNZA'SY]TRC*J?\
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MZ\'_ /?5U_\ &: /SKHK]%/^')?Q3_Z'KP?_ -]77_QFC_AR7\4_^AZ\'_\
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M'_D]KXI?]?MO_P"DD%?-= !1110!^E/_  1#_P"2I_$O_L#6_P#Z/-?K_7Y
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M=H5M)QLM$8X<CLTC%I#W&X+DA17@%%% !1110 *I9@ ,D\ "OZ.?V*_@JWP
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MZU5^2O\ P0Y_Y&KXM_\ 7EIO_HRXK]:J "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KX _X+5_\FL^%O^QSM?\ TAOJ^_Z^ /\
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M\JZ* /U4_P"'YW_5$_\ RZ__ +BH_P"'YW_5$_\ RZ__ +BK\JZ* /TYO/\
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MWW_!9+_DT>S_ .QFLO\ T5<5^(- !1110 5^BG_#[3XI_P#0B^#_ /OFZ_\
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MOSKHH _13_A]I\4_^A%\'_\ ?-U_\>H_X?:?%/\ Z$7P?_WS=?\ QZOSKHH
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M?LZ_$?X ZPVG^//"6HZ"=Y2*[EBWVEP?^F4ZYC?CLK$CN!0!YS1110 4444
M%%%% !1110 445]8_LP_\$V?BM^T7<6FI7>GR>!_!DF';7-9A97F3_IW@.'E
MSV8[4Z_-G@@'SI\-OAKXF^+WC+3?"OA'2+C6M=U"01PVMNN<<\NYZ(B]2S$
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M1OV/_CEKS1BS^$/C4K(%*23Z%<PQL&Z$.Z*N/?/3FOZ2J* /P+\&_P#!+/\
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MF-7E=BS$*K@#D] *P?\ AT_^S;_T*&H?^#N[_P#CE?8%% 'Q_P#\.G_V;?\
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MX(_:4\(6?AGQ[ILVJ:/:7R:E%#!=26Y$ZQR1JVZ-@2-LKC'3GVKTBB@#X_\
M^'3_ .S;_P!"AJ'_ (.[O_XY1_PZ?_9M_P"A0U#_ ,'=W_\ '*^P** /C_\
MX=/_ +-O_0H:A_X.[O\ ^.4?\.G_ -FW_H4-0_\ !W=__'*^P** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
0@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
